Figure 1From: Patient-level pooled analysis of adjudicated gastrointestinal outcomes in celecoxib clinical trials: meta-analysis of 51,000 patients enrolled in 52 randomized trialsIncidence of CSULGIEs. AEs, adverse events; CSULGIEs, clinically significant upper and lower GI events; GI, gastrointestinal; nsNSAID, nonselective nonsteroidal antiinflammatory drug.Back to article page